Prohibitin in squamous cell carcinoma of the lung: Its expression and possible clinical significance

Human Pathology

Volumn 43, Issue 8, 2012, Pages 1282-1288

  Guo, Feng ^a,b   Hiroshima, Kenzo ^b   Wu, Di ^b   Satoh, Mamoru ^a   Abulazi, Mayinuer ^a   Yoshino, Ichiro ^a   Tomonaga, Takeshi ^c   Nomura, Fumio ^a   Nakatani, Yukio ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Tokyo Women s Medical University   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Fluorescent 2 D differential gel electrophoresis; Immunohistochemical analysis; Lung squamous cell carcinoma; Prognostic significance; Prohibitin

Indexed keywords

PROHIBITIN;

ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROTEIN EXPRESSION;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; HUMANS; LUNG; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MITOCHONDRIA; NEOPLASM STAGING; PROGNOSIS; REPRESSOR PROTEINS; SURVIVAL RATE;

EID: 84863984010     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.10.006     Document Type: Article

References (32)

1. S. Hammerschmidt, and H. Wirtz Lung cancer: current diagnosis and treatment Dtsch Arztebl Int 106 2009 809 818
2. G. Ioannidis, V. Georgoulias, and J. Souglakos How close are we to customizing chemotherapy in early non-small cell lung cancer? Ther Adv Med Oncol 3 2011 185 205
3. T. Nishimori, T. Tomonaga, and K. Matsushita Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin Proteomics 6 2006 1011 1018 (Pubitemid 43260225)
4. M. Seimiya, T. Tomonaga, and K. Matsushita Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase Hepatology 48 2008 519 530
5. S. Mishra, L.C. Murphy, B.L. Nyomba, and L.J. Murphy Prohibitin: a potential target for new therapeutics Trends Mol Med 11 2005 192 197
6. M.S. Tsao, N. Liu, and J.R. Chen Different expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancer Lung Cancer 20 1998 1 16 (Pubitemid 28473176)
7. H.W. Tsai, N.H. Chow, C.P. Lin, S.H. Chan, C.Y. Chou, and C.L. Ho The significance of prohibitin and c-met/hepatocye growth factor receptor in the progression of cervical adenocarcinoma Hum Pathol 37 2006 198 204
8. B. Deng, N. Ye, G. Luo, X. Chen, and Y. Wang Proteomics analysis of stage-specific proteins expressed in human squamous cell lung carcinoma tissues Cancer Biomarker 1 2005 279 286
9. B.Q. Hu, G.M. Xiao, Y. Luo, S.L. Zhou, X.P. Xi, and Q.C. Ouyang Screening of molecular markers of lung squamous cell carcinoma by microarrays Zhonghua Zhong liu Za Zhi 26 2004 660 663
10. Y. Qi, J.F. Chiu, L. Wang, D.L. Kwong, and Q.Y. He Comparative proteomic analysis of esophageal squamous cell carcinoma Proteomics 5 2005 2960 2971 (Pubitemid 41059772)
11. D.A. Sewell, C.X. Yuan, and E. Robertson Proteomic signatures in laryngeal squamous cell Carcinoma ORL J Otorhinalaryngol Relat Spec 69 2007 77 84
12. A.S. Vercoutter-Edouart, J. Lemoine, and X. Le Bourthis Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells Cancer Res 61 2001 76 80 (Pubitemid 32095703)
13. S.N. Chow, R.J. Chen, and C.H. Chen Analysis of protein profiles in human epithelial ovarian cancer tissues by proteomic technology Eur J Gynaeclo Oncol 31 2010 55 62
14. M.J. Nueu, D.A. Stewart, and L. Walker Prohibitin, an evolutionarily conserved intracellular protein that block DNA synthesis in normal fibroblasts and HeLa cells Mol cell Biol 11 1991 1372 1381 (Pubitemid 21895493)
15. R. Ummanni, H. Junker, and U. Zimmermana Prohibitin identified by proteomic analysis of prostate biopsies distinguished hyperplasia and cancer Cancer Lett 266 2008 171 185
16. K. Rajalingam, C. Wunder, and V. Brinkmann Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration Nat Cell Biol 7 2005 837 843 (Pubitemid 41079057)
17. S. Wang, N. Nath, M. Adlam, and S. Chellappan Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function Oncogen 18 1999 3501 3510 (Pubitemid 29317345)
18. J.K. McClung, E.R. Jupe, X.T. Liu, and R.T. Dell'Orco Prohibitin: potential role in senescence development and tumor suppression Exp Geronoto 30 1995 99 124
19. A.M. Crarnecka, C. Canpanella, G. Zummo, and F. Gappello Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics Cancer Biol Ther 5 2006 714 720 (Pubitemid 44775122)
20. P.J. Coates, R. Nenutil, and A. McGregor Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence Exp Cell Res 265 2001 262 273 (Pubitemid 32980214)
21. I. Byrjasen, L.P. Mose, and S.J. Fey Two-dimensional gel analysis of human endometrial proteins: characterization of protein with increased expression in hyperplasia and adenocarcinoma Mol Hum Report 8 1999 748 756 (Pubitemid 29366873)
22. T.K. Seow, S.E. Ong, and R.C. Liang Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated protein by mass spectrometry Electrophoresis 21 2000 1787 1813 (Pubitemid 30394872)
23. K. Williamis, C. Chubb, E. Hubermern, and C.S. Giometti Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines Electrophosis 19 1998 333 343 (Pubitemid 28131260)
24. M. Asamoto, and S. Colens Prohibitin gene is over-expressed but not mutated in rat bladder carcinoma and cell lines Cancer Lett 83 1994 201 207 (Pubitemid 24253539)
25. K.J. Wang, R.T. Wang, and J.Z. Zhang Identification of tumor marker using two-dimensional electrophoresis in gastric carcinoma World J Gastroenterol 10 2004 2179 2183
26. J.W. Ryu, H.J. Kim, and Y.S. Lee The proteomics approach to find biomarkers in gastric cancer Korean Med Sci 18 2003 505 509
27. E.R. Jupe, X.T. Liu, J.L. Kiehlbauch, J.K. McClung, and R.T. Dell'Orco Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′ untranslated region mutations Cell Growth Differ 7 1996 871 878 (Pubitemid 26360726)
28. Y. Nan, S. Yang, and Y. Tian Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy Med Oncol 26 2009 215 221
29. C. Li, Z. Xiao, and Z. Cheng Proteome analysis of human lung squamous carcinoma Proteomics 6 2006 547 558 (Pubitemid 43208034)
30. N. Patel, S.K. Chatterjee, and V. Vrbanac Rescue of paclitaxel sensitivity by repression of prohibitin in drug-resistant cancer cells Proc Natl Acad Sci 107 2010 2503 2508
31. T.F. Wu, H. Wu, and Y.W. Wang Prohibitin in the pathogenesis of transitional cell bladder cancer Anticancer Res 27 2007 895 900 (Pubitemid 46586996)
32. H.Z. Ren, J.S. Wang, and G.Q. Pan Increased expression of prohibitin and its relationship with poor prognosis in esophageal squamous cell carcinoma Pathol Oncol Res 16 2010 515 522